Skip to main content
Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.0400
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EST

RMTG Revenue

Regenerative Medical Technology Group had revenue of $1.18M in the quarter ending September 30, 2025, with 19.69% growth. This brings the company's revenue in the last twelve months to $5.04M, up 56.88% year-over-year. In the year 2024, Regenerative Medical Technology Group had annual revenue of $4.11M with 70.44% growth.

Revenue (ttm)
5.04M
Revenue Growth
+56.88%
P/S Ratio
0.10
Revenue / Employee
5.04M
Employees
1
Market Cap
525.56K

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20244.11M1.70M70.44%
Dec 31, 20232.41M879.73K57.49%
Dec 31, 20221.53M1.09M249.46%
Dec 31, 2021437.89K382.81K694.97%
Dec 31, 202055.08K24.98K82.98%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
EV Biologics 9.47M
Sorrento Therapeutics 64.27M
Emmaus Life Sciences 12.45M
SQZ Biotechnologies Company 12.12M
CNBX Pharmaceuticals 40.64K
Iterum Therapeutics 390.00K
Halberd 6.94K
Revenue Rankings

Regenerative Medical Technology Group News

More News